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ABSTRACT
CLONING AND CELL CYCLE ANALYSIS OF NUMA, A PHOSPHOPROTEIN THAT OSCILLTES
BETWEEN THE NUCLEUS AND THE MITOTIC SPINDLE
Cynthia A. Sparks
University of Massachusetts Graduate School
of Biomedical Sciences
1995
The overall objective of this study was to identify novel proteins of the nuclear matrix in
order to contribute to a better understanding of nuclear structure and organization. To
accomplish this, a monoclonal antibody specific for the nuclear matrix was used to screen
a human Agt11 expression library. Several cDNAs were isolated, cloned, sequenced, and
shown to represent NuMA, the nuclear mitotic spindle apparatus protein. Further
characterization of the gene and RNA was undertaken in an effort to obtain information
about NuMA. The NuMA gene was present at a single site on human chromosome 11 q13.
Northern and PCR analysis of NuMA mRNA showed a major 7.2 kb transcript and minor
forms of 8.0 and 3.0 kb. The minor forms were shown to be alternatively spliced although
their functional significance is not yet understood. Immunofluorescence microscopy
demonstrated that NuMA oscilates between the nucleus and the microtubule spindle
apparatus during the mitotic cell cycle. NuMA appeared as a 200-275 kDa protein
detectable in all mammalian cells except human neutrophils. To determine whether
NuMA' s changes in intracellular distribution correlated with post-translational
modifications, the protein s phosphorylation state was examined through the cell cycle
using highly synchronized cells. NuMA was a phosphoprotein in interphase and underwent
additional phosphorylation events in mitosis. The mitotic phosphorylation events occurred
with similar timing to lamin B (G2/M transition) and were concomitant with NuMA'
release from the nucleus and its association with the mitotic spindle. However
, the mitotic
phosphorylation occurred in the absence of spindle formation. Dephosphorylation of NuMA
did not correlate with reassociation with the nuclear matrix but occurred in two distinct
steps after nuclear reformation. Based on the timing of these events, phosphorylation may
playa role in nuclear processes. In conclusion , the work in this dissertation identified
NuMA , a nuclear matrix protein and showed that it is phosphorylated during the cell cycle
and may be important for nuclear events such as nuclear organization
, transcription , or
initiation of DNA replication at G1/S.
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CHAPTER 1
INTRODUCTION
A. Specific Aims
The overall objective of this dissertation was to contribute to our understanding of the
nuclear matrix. This study was based on the fundamental principle that structure is
important for biological function. For example , the specialized architecture of the
nuclear matrix may affect the highly regulated and essential functions of the
mammalian nucleus. The goal of this work was to identify and analyze a specific nuclear
matrix protein component. When the identity of the nuclear matrix protein examined in
this study was revealed to be NuMA , the overall objectives were expanded to encompass
the role of this protein in another highly specialized structure , the mitotic spindle. The
specific goals of this study were:
1. To identify the protein that reacts with a nuclear matrix antibody by isolating cDNAs
and obtaining sequence information
2. To obtain information about the gene and mRNA including:
Characterize the gene for size and complexity
Map the position of this novel gene in the human genome
Characterize the mRNA in terms of size and relative abundance
Identify mRNA isoforms
3. To obtain information about the protein including:
Characterize the subcellular distribution through the cell cycle
Determine the size and complexity of the protein
Determine if the protein is phosphorylated
4. To obtain specific information about the protein through the cell cycle that may
relate to its function including:
Changes in subcellular localization
Changes in phosphorylation state
Changes in solubility
The objectives of this dissertation are best appreciated after examining what is known
about the nuclear matrix, NuMA , and mitosis. The next three sections respectively wil
review these areas of investigation.
B. The nuclear matrix.
The nuclear matrix is defined as a fibrilogranular network including the nuclear
lamina and an interior protein scaffold that resists extraction with detergents , digestion
with nucleases, and extraction with elevated ionic strength (1-9). The nuclear matrix
was first described by Berezney and Coffey (1 , 10) as the residual nuclear structure in
rat liver cells remaining after sequential extraction with non- ionic detergents
digestion with DNase I , and extraction with 2 M NaCI. These extractions removed most
proteins, lipids , and nucleic acids , yet from examination at the level of the electron
microscope , the remaining structure retained the original nuclear shape and size
characteristics. Further investigations supported these observations although
methodologies varied and structures were assigned a variety of names (nuclear scaffold
- (11), nucleoskeleton - (12)). Nevertheless , these nuclear substructures contained
essentially the same components: the nuclear lamina, the nuclear pore proteins , and an
intranuclear fibril log ranular network composed of protein and RNA (Figure 1 , (6)).
The structures and their variations have been reviewed (13- 16).
. ,._.
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FIG 1. Nuclear matrix electron micrograph. Nuclear matrix observed using
resinless electron microscopy. (a) The nuclear matrix- intermediate filament scaffold is
imaged as a whole mount. (b) When the interior of the nuclear matrix is examined under
conditions that preserve hnRNA, the RNP-containing nuclear matrix is shown to be a
network of filaments. Taken from Fey et al. J. Cell BioI. 102:1654 (1986).

Ext nsive studies have suggested roles for the nuclear matrix in nuclear functions. Most
of these studies demonstrated association of particular molecules or biological activities
with the nuclear matrix. The role of the nuclear matrix in the function of these
molecules or activities was then hypothesized based on a physical association. These
investigations have indicated a variety of roles for the nuclear matrix in nuclear
functions, reviewed in (13-19). The nuclear matrix appeared to be a site for binding
DNA via matrix attachment regions (MAR) to loops of DNA (11 , 20). The sites for DNA
replication were found in association with the nuclear matrix (21-26). HnRNA was
associated with the nuclear matrix (5 , 6 , 27 , 28), and the matrix acted as a site for the
efficient splicing of mRNA (29). These results were somewhat controversial. One
report had most of the active RNA polymerase associated with the nucleoskeleton (12)
while another report had contradictory results (30). It is possible that the harsh
treatment used to isolate the nuclear matrix (such as high salt extraction) caused
artifactual association . of some molecules (17 , 31).
Despite a number of studies indicating a relationship between the nuclear matrix and
nuclear functions , the significance of this relationship remains in question. Advances
are hampered by the nebulous definition of the nuclear matrix based on isolation
procedures. The field would benefit greatly by approaching the functions of the nuclear
matrix at the molecular level. The proteins and RNAs that comprise the nuclear matrix
need to be identified and evaluated for direct roles in nuclear processes , perhaps based
:'.
on interactions with nuclear compartments such as DNA replication sites or splicing
domains. One of the difficulties in studying these proteins is their relatively low
abundance. The lam ins and nuclear pore proteins comprise more than half of the total
nuclear matrix proteins (1). The remaining components of the interior matrix are
present in low abundance making standard biochemical techniques problematic.
Monoclonal and polyclonal antibodies to nuclear matrix proteins have been developed at
Matritech, Inc (Cambridge, MA). One of the monoclonal antibodies , 204.41 , was the
initial tool used to identify a novel nuclear matrix protein. It was the fundamental goal
of this dissertation to identify a nuclear matrix protein and provide information about
its relationship to the nucleus and nuclear function. The nuclear matrix protein
identified in this study was NuMA.
NuMA
NuMA was first identified in 1980 by Lydersen and Pettijohn using antisera raised
against HeLa cell non-histone chromosome proteins (32) and was characterized in
several subsequent studies (33-36). It was found to be a single 240 kDa protein in
human cells but also was present in many other species (34 , 37). By analyzing cells at
different stages of the cell cycle by immunofluorescence microscopy, NuMA appeared as
granular staining in the nucleus at interphase , associated with the spindle poles at
metaphase, and returned to the reforming nucleus in telophase (For a review, see
(38))32 , 34, 37 , 39-43), and this study) regardless of the fixation method used
(39). In many of the earlier studies , this protein was described using different names
(centrophilin (39), SPN (37), SPH (40)). Immunofluorescence experiments with
metaphase chromosomes suggested that NuMA may associate with centromeres, although
not consistently from experiment to experiment (34, 36, 39, 44).
NuMA is a highly antigenic protein (45) as evidenced by its abilty to ilicit an immune
response when prepared from fractions as varied as kinetochores (39), crude nuclear
preparations (37), nuclear matrix protein preparations (this study), non-histone
chromosome proteins (32), chromosome scaffolds (41), and epithelial cell nuclei (43).
Lnterestingly, some patients with autoimmune diseases have antibodies directed against
the NuMA protein (33, 40 , 42 , 46). The full length cDNA has been cloned by several
groupS (42-45), and the amino acid sequence predicts a large coiled-coil protein
flanked by non-coiled ends (42).
Northern analysis revealed a 7.2 kb mRNA and at least two other minor RNA isoforms
(this study, (43)). Overexpression of the protein encoded by the minor mRNA isoforms
in mammalian cells showed localization of the protein to the centrosome (47). A
different study proposed that NuMA isoforms may participate in organization of pre-
mRNA splicing domains based on data obtained with a specific antibody (48). The
nuclear localization signal was found in the C-terminus of the protein (45 , 47, 49),
specifically at amino acid residues 1972-2007 (47). A larger region was found to be
responsible for spindle localization , at amino acid residues 1516- 1667 by expression
studies with NuMA deletion constructs (47).
The function of NuMA is unknown. Most studies have concluded that NuMA may have a
role in stabilzing the mitotic spindle. These results have been summarized in Table 1.
It is known that intact microtubules are required for NuMA's spindle association.
Treatment with microtubule depolymerizing agents such as nocodazole disrupts the
spindle and NuMA disperses throughout the cell , see Figure 21 (32 , 37 , 39). If you
wash away the drug, NuMA will concentrate at the microtubule nucleation sites (39).
Taxol- induced microtubule asters contain NuMA at the minus end of the microtubules
(40, 50). NuMA will co-sediment with purified microtubules in vitro (40 , 50). Thus
there appears to be a physical relationship between NuMA and spindle microtubules.
. ..
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TABLE 1. - Summary of NuMA Studies. Various features and functions of NuMA are
summarized with experimental procedures used and references to which groups did each
study to date.
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NuMA may also have a functional relationship with the mitotic spindle. In contrast, it
has also been suggested that there may be no function for NuMA at the spindle except to
redistribute the protein efficiently to each daughter cell (41 J. NuMA antibody
microinjection studies resulted in blocking the formation of or collapse of the spindle
apparatus (34, 37, 51 J and concluded that NuMA is required for spindle integrity in
the early phases of the mitotic cell cycle. Another result showed that microinjection of
a monoclonal antibody could reverse taxol- induced aster formation in Ptk2 cells. Non-
taxol treated cells in this study had normal mitoses but formed micronuclei after
completing mitosis (52). A study using a polyclonal antibody microinjected into cells
entering early mitotic stages showed that these cells were unable to form a spindle, but
in later stages (anaphase or beyond), the antibody had no effect on cells (51). These and
other functional studies have been summarized in a recent review (38). From these
studies, it appears that NuMA may have a role in the formation and stabilty of the
mitotic spindle.
Examination of NuMA's distribution through the cell cycle shows that NuMA leaves
the spindle poles in late anaphase/early telophase when the nucleus reforms leading
to a second hypothesis that NuMA may playa role in this process (34). In support of
this, microinjection studies have often resulted in the formation of micronuclei , a
phenotype that some groups have characterized as a nuclear reformation defect (44
49, 52). Overexpression of truncated forms of NuMA lacking the n- or c-terminal
globular domains also resulted in this phenotype (49). One study showed that
overexpressed human NuMA can rescue the micronucleation phenotype induced in the
hamster cell line tsBN2 carrying a mutation in the nuclear chromosomal binding
protein RCC1 (49). Together with the knowledge that NuMA is a nuclear matrix
protein (see below), these studies indicate that NuMA may have a role in nuclear
reformation.
NuMA is a component of the nuclear matrix (this study, (32 , 37, 41)). NuMA appears to
be a component of the fibers that form the core fiamenVnetwork of the nucleus, as shown
by immuno-gold electron microscopy (54). This localization of NuMA in the
fibrilogranular network complements the functional data suggesting a role in stabilizing
the nucleus and mitotic spindle. Some important questions remaining from these
observations include how NuMA contributes to the stabilization of these structures and the
identity of the proteins or RNAs that interact with NuMA. In addition, the mechanism for
NuMA' s movement between the nucleus and spindle is not understood.
D. Mitosis and the Spindle
The process of cell division can be broken into 6 linear stages applicable to eucaryotic
organisms: prophase, prometaphase, metaphase, anaphase, telophase, and cytokinesis (an
exception to the linear arrangement, cytokinesis overlaps with anaphase and telophase).
These stages together are termed mitosis (see reviews (55, 56)). This process ensures
that all proteins, RNA , and DNA are properly segregated into each daughter cell. At mitosis,
there is a dramatic rearrangement of cellular components such as the cytoplasmic
microtubules, which reorganize to form the mitotic spindle apparatus. This microtubule
reorganization is largely due to the centrosome, the principal microtubule organizing
center of the cell , which duplicates and separates to opposite poles by prometaphase. At
mitosis, biological activities are altered such as protein synthesis drops to approximately
25%, and RNA synthesis stops.
The mitotic spindle is the machinery responsible for the segregation of chromosomes. At
prophase, the duplicate chromosomes condense, and various types of microtubules begin
assembling the spindle. In higher eucaryotes, the nucleus and nuclear envelope break down
at prometaphase, allowing the spindle microtubules to capture the chromosomes and align
them to form a "metaphase plate . At anaphase, sister chromatids separate and move via
molecular motors along the microtubules to the poles. At telophase, the nuclear envelope
begins to reform around the chromosomes which decondense, and the nucleus assembles
(57) .
Segregation of cellular components occurs in many ways. Many organelles are divided into
each cell by simply doubling in amount or breaking up into vesicles and associating with the
mitotic spindle. The association with the spindle may guarantee equal distribution into
daughter cells. Segregation of nuclear matrix proteins may occur using several different
pathways. Some nuclear matrix proteins have been observed in the structures of mitotic
chromosomes (58), whereas NuMA appears to be segregated by association with the spindle
pole (44).
Entry of eucaryotic cells into mitosis is regulated by a cascade of kinase activities.
Phosphorylation of MPF , a complex of cyclin Band cdc2 kinase, initiates mitosis (see
(59J). Activation of cdc2 kinase by binding to cyclin B is followed by initiation of nuclear
envelope breakdown and DNA condensation. As cells enter telophase, the final stage of
mitosis, nuclear reformation is accompanied by degradation of cyclin B , deactivation of
MPF , and dephosphorylation of many proteins. (60-64). Several substrates for cdc2 have
been proposed, of which lam in B is the best characterized. Lamin B is phosphorylated in
prophase, leading to the disassembly of the nuclear lamina. Lamin B dephosphorylation
drives its reassembly into reforming nuclei beginning in late anaphase continuing through
early G1 (65- 70).
There is evidence that phosphorylation may regulate the function or 
localization of NuMA in
the cell. A basal level of NuMA phosphorylation has been demonstrated using HeLa cells (34
53). NuMA from mitotic cells is also phosphorylated (this study, (53)). Analysis of the
amino acid sequence of NuMA predicts over 24 phosphorylation sites for a variety of
kinases (42) including four sites for cdc2 kinase
, all at the C- terminus. Site-directed
mutagenesis of these four sites results in failure in spindle 
localization and aberrant
spindle formation (53). Although NuMA is demonstrated to be a phosphoprotein in that
study, a direct role for phosphorylation in the aberrant localization has not been
demonstrated. This may be the result of secondary effects of the point mutations such as
misfolding of the protein. Furthermore, given the basal level of phosphorylation
, the
regulation of NuMA may be quite complicated.
SUMMARY
In summary, the nuclear matrix is operationally defined as the fibrillogranular network
that remains following sequential extraction with detergents, digestion with nucleases, and
extraction with high salt. The nuclear matrix has been implicated in many nuclear
processes including DNA replication
, transcription , and chromatin organization. This
investigation identified perhaps the first protein 
component unique to the interior of the
nuclear matrix, NuMA. With the identity known for one nuclear matrix protein
, the door
has been opened to finding other components based on their interaction with NuMA. This
study is only a beginning to the understanding of how the proteins of the nuclear matrix
form -this structure and contribute to nuclear functions.
At mitosis, NuMA redistributes from the nucleus to the spindle pole. The protein has been
examined during mitosis for changes in biochemical properties. The discovery of mitosis-
specific changes in NuMA phosphorylation has been pivotal in permitting one to examine
how the protein is regulated in a cell cycle-specific manner and if these changes directly
affect properties such as subcellular localization. To begin to answer these questions, the
effects of phosphorylation on other properties of NuMA , such as solubility, were examined
in this dissertation. While one study will not answer every question, it is hoped that this
work wil contribute to a better understanding of the mechanisms by which the cell
regulates proteins participating in such complex tasks as nuclear organization and cell
division. What remains to be answered by future studies includes the identity of binding
partners and the identification of the signal transduction pathways involved in the cell
cycle-specific regulation through defining the kinases and phosphatases acting on NuMA.
CHAPTER 2
MATERIAL AND METHODS
A. Cells, Cell lines and Tissue Culture
Chinese hamster ovary (CHO) cells, ME180 human cervical cells, HL-60 human
premyeloblastic cells, NIH3T3 mouse fibroblast cells, and MCF7 human breast carcinoma
cell lines (ATCC, Rockvile, MD) were maintained in a 5% C02 incubator at 37 C in
Dulbecco s minimal essential media (DMEM , Gibco-BRULife Technologies, Gaitherburg,
MD) supplemented with 10% fetal calf serum or iron-supplemented calf serum (Hyclone,
Logan, UT), 50 ug/ml streptomycin , and 50 U/ml penicilln prior to use in
immunofluorescence experiments, and purifications of RNA , protein, and DNA. Purified
Purified human granulocytes were generously provided by Dr. Richard Jack (Harvard
University, Cambridge, MA).
B. Antibodies
Lamin B monoclonal, NuMA monoclonals 204.41, 107.7, and 302. , NuMA
polyclonal, and TPR monoclonal antibodies were obtained from Matritech Inc.
(Cambridge MA). Other antibodies were obtained from the following: tubulin monoclonal
antibody from Sigma Chemical (DM1 ex, St. Louis, MO), lamin B polyclonal antibodies
from Dr. H. Worman (71), pericentrin monoclonal antibodies from Drs. S. Doxsey and
J. Burkhart (UCSF), and polyclonal pericentrin antibodies from Dr. S. Doxsey(72).
C. Cloning and sequencing cDNAs
The 204.41 antibody was used to screen a Agt11 human cervical cDNA expression
library (Clontech , Palo Alto, CA). Library screening was performed essentially as
described in Sambrook (73). The cDNA inserts from each clone were amplified by PCR
(74) and used for mapping and sequencing experiments. Amplified DNA inserts were
visualized on 1% agarose/TBE gels to determine the size of the inserts in each Agt11
clone. Double stranded PCR products were digested with a number of restriction
enzymes (Boehringer Mannheim Biochemical (BMB), Indianapolis, IN), and individual
clones were aligned. The cDNA sequences were obtained using a Taq polymerase
sequencing system (Promega, Madison , WI) with a thermal cycler (MJ Research
Watertown, MA). Primers to the Agt11 cloning site were used to initially sequence
double stranded cDNA clones. Internal restriction fragments were subcloned into
pBluescript SK+ (Stratagene, LaJolla, CA). Single stranded DNA from subclones was
prepared according to manufacturer s instructions and both single and double stranded
clones were sequenced with pBluescript SK+/-specific primers. In some cases,
synthetic oligonucleotide primers were designed using the Oligo software (National
Biosciences, Inc., Plymouth, MN) and used as sequencing primers to obtain a complete
sequence of individual clones. Sequence analysis was done by searching the Genbank
database using the TFAST A program (75).
D. Northern and Southern blots
ME180 total or Poly A+ RNA was isolated using cesium chloride procedures described
in Sambrook (73) or using the Fastrack RNA isolation kit (Invitrogen, San Diego, CA)
according to manufacturer s instructions. RNA was separated by electrophoresis in 1 %
agarose/formaldehyde/MOPS gels, blotted, and probed with cDNA probes radiolabeled by
PCR direct incorporation or random-primed 32p-dCTP incorporation using standard
methods (73). Slot!? were exposed to autoradiographic film for 1-21 days at -700C
with an intensifying screen.
For Southern blot analysis, cDNA probes were labeled by random primed incorporation
with digoxygenin dUTP. Total cellular DNA was prepared from ME180 cervical
carcinoma cells, digested with a variety of restriction enzymes (BMB), separated on
8% agaroselTBE gels, and blotted onto nylon membranes essentially as described in
Sambrook (73). Results were visualized using the Genius system (BMB).
E. Fluorescence In Situ Hybridization
Two cDNA clones encompassing approximately 2.5 kb of the NuMA sequence at positions
3428 - 5450 (42) were used as templates for digoxygenin probe synthesis.
Hybridizations were performed essentially as described by Lawrence (76). Metaphase
spreads were prepared from normal peripheral blood lymphocytes using standard
procedures and stored at - C. Slides were baked at 65 C for 5 hours, rinsed in 2 X
SSC, and denatured in 70% formamide, 2 X SSC for 2 minutes at 70 C followed by
dehydration in graded ethanol series and air drying. 50 ng of NuMA cDNAs were labeled
by nick translation in the presence of digoxygenin dUTP (BMB), denatured and mixed
with hybridization buffer (2:1:1:1 - 50% dextran sulfate, 10 mg/ml BSA , 20XSSC,
double distiled deionized water). Labeled probe was added to the slides and incubated
overnight at 37 C. Slides were washed in 2 X SSC/50% formamide for 30 minutes, 2 X
SSC for 30 minutes, 1 X SSC for 30 minutes, then incubated with an anti-digoxygenin
antibody conjugated directly to fluorescein or rhodamine (1 :500 , BMB). Slides were
counterstained with DAPI to identify individual 
chromosomes and banding patterns.
Slides were mounted in 90% glycerol
, 0.1 % phenyline diamine and viewed by
fluorescence microscopy. Photography was done using Kodak (Rochester
, NY)
Ektachrome 400 slide fim exposing for 1-5 minutes or with Ektar 1000 print fim at
2 minute exposure times.
F. PCR Analyses
ME180 Poly A+ RNA was oligo dT-primed and reverse transcribed into cDNA using the
cDNA cycle system (lnvitrogen). This cDNA was used as a template in PCR 
reactions
using a variety of primers to NuMA. Alternatively, genomic DNA was prepared as
described above and analyzed with PCR and similar primers. Results were visualized on
1% agaroselTBE gels stained with ethidium bromide. Various PCR products were
subcloned into pCR vectors with the TA cloning system (Invitrogen) and sequenced.
G. Immunofluorescence
Cells were grown or cytospun onto poly-
Iysine coated coverslips or at 30 x g. 
for 10
minutes. Coverslips were washed in PBS (137 mM NaCI
, 2.7 mM KCI , 10 mm
Na2HP04, 1.8 mM KH2P0 , pH 7.4), fixed and extracted at the same time in 3.
formaldehyde in cytoskeletal (CSK) buffer (0.5% Triton X-100, 100 mM NaCI , 300
mM sucrose, 10 mM Pipes pH 6.8, 3 mM MgCI2, 1 mM EGT A) for 15 minutes at room
temperature or in - C methanol for 15 minutes. In some cases, cells were extracted
for 5 minutes at room temperature then fixed in - C methanol for 15 minutes.
Isolated centrosomes were prepared as previously described (72). All subsequent steps
were done at room temperature in a humid chamber. Covers lips were washed twice with
PBS, and blocked in PBSA T (0.5% Bovine Serum Albumin-BSA and 0. 1 % Triton X-100
in PBS) for 5 minutes. Primary antibodies were diluted in PBSA T and incubated for 30
minutes. Coverslips were washed 3X in PBSA T and incubated in secondary antibodies,
goat anti-mouse, rabbit, or rat conjugated to fluorescein or rhodamine (Jackson
ImmunoResearch Labs, West Grove, PN) for 20 minutes. Coverslips were washed for
one minute twice in PBSAT, once in PBS, once in PBS with DAPI (2 ug/ml, Sigma) to
detect DNA , twice in PBS and mounted in glycerol with phenyline diamine (100 ug/ml
Sigma). Microscopy was done on an Axioplan immunofluorescence microscope (Carl
Zeiss, Oberkochen , Germany) with a Photometrics 200 series CCD camera (Tuscon, Az)
or an Axioscope immunofluorescence microscope (Carl Zeiss).
H. Preparation of Protein Extracts
i. Total Protein
Protein extracts were prepared from various cell lines by lysing in a modified RIPA
buffer (180 mM NaCI, 1 % NP-40, 0.5% Deoxycholate, 0. 1 % SDS, 50 mM Tris, pH
0) containing protease and phosphatase inhibitors (0. 15 ug/ml phenyl methyl
sulfonyl fluoride - (PMSF); 10 ug/ml each - aprotinin , leupeptin, chymostatin; 5 
EDT A; 2.5 mM beta-glycerol phosphate; 100 uM sodium vanadate) for ten minutes at
C (77). In some cases, phosphatase inhibitors were omitted (Figure 17A). Lysates
were cleared by spinning at 50,000 x g for 5 minutes at 4 C. Relative protein
concentrations were determined using a Coomassie assay (Biorad Labs, Hercules, CA)
according to manufacturer s instructions with BSA as a standard. Alternatively, cells
were lysed in a buffer containing 8M urea, 2% nonidet P40
, and 2% 
mercaptoethanol.
ii. 35S and 32p labeling
CHO cells or ME180 cells were grown in T- 175 cm2 flasks, washed twice in
phosphate-free DMEM with 10% dialyzed serum , and incubated for 4 hours in
phosphate-free DMEM with 10% dialyzed serum and 32P-orthophosphoric acid (2
mCi/ml, DuponVNEN Boston, MA). These cells were washed twice in cold PBS, and
lysed at 4 C as described above. To obtain 32P- labeled mitotic cells, cultures were
treated with 5 ug/ml nocodazole for 4 hours, collected by mitotic shake-off
, rinsed in
cold PBS, and protein extracts were prepared from them as described above. An average
of 104 105 mitotic cells was obtained as determined by cell counts done on unlabeled
populations of CHO cells.
iii. Synchronized Cell Extracts
Mitotic CHO cells were prepared using two methods. For most experiments described in
this study, mitotic (M) cells were obtained by Dr. Charles Vidair
, UCSF , using a drug-
free manual shake-off protocol described in detail elsewhere (78) that typically
produces populations with mitotic indices between 97-99% (data not shown). These
mitotic populations were frozen and stored according to the method of Borrelli (79).
Cells frozen in this way show no significant reduction in viability following thawing and
plating and progress rapidly and synchronously through the cell cycle. It should be
noted that the electrophoretic mobility of NuMA was unaffected by this procedure
(Figure 23B, lane 1*). A second method used to obtain mitotic cells involved arresting
them at mitosis with nocodazole (5 ug/ml) for 4 hours and collecting them by shaking
manually. The nocodazole-blocked (N) mitotic cells consist of 90% prometaphase cells
(data not shown and (80)).
Asynchronous CHO cells were grown to 95% confluency (5 x 106 cells per 100 mm
plate) then washed three times in PBS to remove mitotic cells leaving 
95%
interphase (I) cells (see below). To obtain cells in various stages of the cell cycle,
mitotic (M) cells (above) were thawed rapidly at 370C, gently spun through 5 ml of
ice-cold PBS at 30 x g, plated into 370C media, and pelleted at various periods of time
after release (anaphase -10 minutes, telophase -25 minutes, G1 E- 60 minutes, and
G1 L- 240 minutes). 5 x 106 cells from each time point were pelleted and lysed in a
modified RIPA buffer (above). Populations of G2 Chinese hamster cells were a generous
gift of Dr. V. Prem Reddy, UMMC, Worcester MA.
iv. Cell fractionation
For isolation of soluble fractions, cells were extracted with a Triton buffer (CSK). The
remaining protein was solubilzed in the modified RIPA buffer (above) or in a buffer
containing 8M urea, 2% nonidet P40, and 2% -mercaptoethanol and used as an
insoluble fraction. Nuclear matrix- intermediate filament extracts were prepared as
previously described (5). For nuclear matrix immunofluorescence, cells on coverslips
were extracted 3X for 5 minutes with CSK buffer on ice, then extracted in digestion
buffer (CSK with only 50mM NaCI , plus 100 ug/ml Dnase I , Sigma) for 20 minutes at
room temperature. Coverslips were extracted with CSK containing 0.25M (NH4)2S04,
washed with CSK buffer , fixed in - C methanol , and processed as described above.
I. Immunoprecipitation and Western blot analysis
CeU Iysates (above) were cleared of 
non-specific binding by preincubation with 20 ul
of Protein A agarose beads (Gibco BRL) for 30 minutes at 4 C in an orbital shaker.
After preclearing, 3 ug of each polyclonal antibody was added to 250 ul of a cell extract
and incubated for one hour in the cold in an orbital shaker. Immune complexes were
collected by incubation with 30 ul of Protein A or G beads for 3 hours in the cold and
pelleting the bead-protein complex by centrifugation at 10,000 x g for 15 seconds.
Beads were washed three times with lysis buffer then resuspended in 30 ul of SDS
sample buffer.
polyacrylamide gels were run according to the method of Laemmli (81). In order to
detect mitotic shifts (Figures. 18-20, 23), 5% polyacrylamide gels were run on 11-
12 cm resolving gels until the 200 kDa myosin marker reached the bottom of the gel.
SDS-PAGE was followed by transfer to Immobilon-P nylon (Millipore Corporation,
Bedford, MA) using a semi-dry blotting apparatus (Owl Scientific, Cambridge, MA).
Blots were incubated in 5% blocking agent (Biorad Labs) in TBS (20 mM Tris.HCL pH
5, 0.5M NaCI) then exposed to antibodies (final IgG concentration 1-3 ug/ml) for one
hour in TBS containing 1 % blocking agent and 1 % BSA at room temperature. After three
washes in TBST (TBS, 0.05% Tween 20), blots were incubated in secondary antibodies
(goat anti-mouse or goat anti-rabbit alkaline phosphatase conjugate, Biorad Labs) for
one hour at room temperature. Blots were washed 3X in TBST, once in TBS then
incubated for 5 minutes in Immunlite chemiluminescent substrate (Biorad Labs) and
exposed to reflection film (Dupont /NEN) for 5 minutes to 3 hours at room
temperature.
. ---.-.-- -...
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J. Phosphatase Treatment
After immunoprecipitation, bead pellets were washed three times in phosphatase buffer
(20 mM Hepes, pH 7.4, 100 mM NaCI, 1 mM DTT, 1 mM MgCI2, 0. 1 mM ZnCI2) then
incubated with 96 units of calf intestinal alkaline phosphatase (Sigma) at 37 C for 30
minutes (82). The pellets were washed three times in phosphatase buffer then
resuspended in SDS sample buffer and analyzed by immunoblotting.
CHAPTER 3
Identiication and Characterization of the NuMA gene and mRNA
To begin to understand the nature and function of the nuclear matrix, this study has
been designed to identify protein components by molecular cloning. From the time of its
first description (1), the nuclear matrix has been the subject of numerous studies
suggesting that it may playa functional role in fundamental nuclear processes such as
DNA replication, transcription, and chromatin organization. Several comprehensive
reviews of these investigations have been written (13-16). Despite extensive evidence
in support of a nonchromatin nuclear structure that is important in nuclear function
the nuclear matrix is somewhat controversial. The main criticism is that it has not
been confirmed in the intact cell and therefore the structure identified after extractions
may not accurately reflect the in vivo structure of the nuclear interior (17). The
components of the nuclear matrix that have been identified could have been trapped by
the stringent methodologies used to prepare the samples. Identification of a resident
protein component of the fibrilogranular network of the nuclear matrix and
localization to this structure both in vivo and in vitro will contribute greatly to its
validation and the ability to examine a functional relationship with the nucleus.
In this chapter, a novel nuclear matrix protein was identified using a molecular cloning
strategy. Antibodies to nuclear matrix preparations were used to isolate cDNAs. Once
sequenced, these cDNAs were used as tools to examine the gene and messenger RNA. The
rationale for this strategy was that monoclonal antibodies raised against nuclear matrix
fractions would provide specific tools that would allow for isolation of a nuclear matrix
cDNA and thereby, identification of a novel protein component of the nuclear matrix.
Once identified, the cDNAs and antibodies would be used for an examination of the gene
and mRNA in the hopes of obtaining basic information about the structure and function
of the molecule and thereby better understand the nuclear matrix. This characterization
should provide insight into specific properties of the protein. The sequence information
should allow for prediction of the secondary and tertiary structure that could provide
clues to the molecular structure of components of the nuclear matrix. The sequence data
would also provide insight into nuclear localization signals, binding motifs, and
regulatory sites. In addition, mapping the position of the gene in the human genome
would possibly provide a link to a genetic disease and allude to a function for the
protein. Examination of RNA expression patterns may lead to mechanisms used to
transcriptionally regulate the levels of the protein. In summary, the objective of this
chapter is to clone, sequence and characterize a novel protein at the level of the gene and
mRNA in the hopes of advancing our understanding of the structure and function of the
nuclear matrix.
RESUL TS
A. cDNA isolation and identification of a novel nuclear matrix protein
The 204.41 nuclear matrix antibody was used to screen several human Agt11
expression libraries. The screenings resulted in the isolation of 3 major clones
""'
encoding polypeptides that react strongly with the 204.41 antibody. Two clones, NMP4
and NMP8 were initially isolated by a rotating student (G. McNeil). Analysis of these
clones began with amplification of the inserts using the PCR and Agt11 primers to
assess clone size. DNA was purified from a variety of sources (phage - single or double
stranded, PCR products or subcloned plasm ids) and digested with several restriction
endonucleases (not shown). The individual insert restriction maps were compiled. The
cloned fragments of the cDNAs were sequenced using the Taq sequencing system
(Promega, Madison , WI). Using this kit, up to 500 bp of sequence from purified lambda
DNA were routinely obtained. Results from these analyses identified overlapping
sequences between each clone. Using the data obtained from restriction mapping and
sequencing, the clones were aligned. This work has been summarized in Figure 2. As
sequences became available, regular searches were conducted on Genbank for
homologous sequences. Initially, all cDNA sequence was found to be unique and not
homologous to any nucleic acid sequence yet reported.
The full sequence of the clones was obtained by subcloning the inserts into several
different plasmid vectors (Table 2). Larger clones required digestion with Pst I, and
cDNA fragments were subcloned. Oligonucleotide primers were made in order to
complete the sequencing of the larger inserts. The sequencing of these overlapping cDNA
clones was completed at the same time that the sequence became available in Genbank.
The cloned cDNA sequences revealed 98% identity to NuMA (42, 44). Figure 3
represents the sequence of the cDNA clones from this study aligned to the sequence of
NuMA at bases 3428-5813 (42).
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Table 2 - NuMA cDNA Subclones
Insert(bp)277 
(-)
508 859 
+)
859 508 630 
( - )
orientation Position in 204.
2171- 2448
1826- 2334
5039- 5898(Yang)
5039- 5898(Yang)
1826- 2334
1826- 2334(+120)
1826- 2334
1826- 2334
1826- 2334
2171- 2448
2171- 2448
88- 282
4200- 4820(Yang)
42 0 0 - 4 8 2 O( Y a n 9 )
88- 282
282- 370
Clone 
Vector
pCS1 pCR1000
pCS2 pCRIl
pCS3 pCR1000
pCS4 pCR1000
pCS6 pCR1000
pCS7 pCRIl
pCS8 pCR1000
pCS9 pCR1000
pCS10 pCR1000
pCS14 pCR1000 277
pCS17 pCR1000 
277D9 pSK+ 194
S C 12 pSK+ 
620
SC- 10 pSK+ 620C1 pSK+ 194C2 pSK+ 
( - )( 
TABLE 2. Various sections of cDNAs were subcloned into different vectors for the
sequencing project. These tools were then used in subsequent molecular analyses. The
table gives the clone name, then the vector used, followed by the insert size in bp, then
the orientation of the insert relative to the T7 promoter common to all vectors , and
lastly the position of the clone in the 204.41 cDNA unless otherwise indicated ("Yang
indicates the position in the sequence published by Yang and Snyder, 1992 (51).
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FIG. 3. NuMA sequence. The sequence obtained from the 204.41 cDNA clones in
alignment with sequence to NuMA, the nuclear mitotic apparatus protein , at positions
3420-5820 (42).
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. ; . B. Characterization of NuMA mRNA
In order to assess the size of the mRNA , Northern blot analysis was performed. Total or
poly A+ RNA from ME180 cells was isolated and separated on 1 % agarose-
c .
~~~
formaldehyde-MOPS gels , and transferred onto nylon membranes. Blots were probed
; :'.
v,',i:.
with cDNA clones radiolabeled with 32p-dCTP by PCR direct incorporation in most
cases. This analysis resulted in the detection of two low abundance mRNAs for NuMA
(Figure 4 , middle lane , see Figure 11 also). The major form was at 7.2 kb with a
minor form at approximately 8.0 kb. Another study described similar results but
estimated the sizes to be a major 8. 5 kb thick band and a minor 9.2 kb band (43).
As a control , Northern blots were done with another probe. A probe to the nuclear pore
protein, TPR , detected a large - 5 kb band (Figure 4, left lane). 28s and 18s
ribosomal RNAs served as markers and positions are indicated by arrowheads. Thus, the
NuMA mRNAs consist of several forms including a major 7.2 kb form and a minor 8.
kb form.
C. Analysis of the NuMA gene
As a first characterization of the gene for NuMA, we wanted to map its position in the
human genome. This analysis may provide insight into a function for NuMA (if 
mapped to a disease position). This technique may also provide insight into whether
NuMA was a single copy gene or the member of a multi-gene family. Two approaches
were used to examine this , Southern blot analysis and fluorescence in situ
hybridization. Southern blot analysis was conducted to determine the size and
complexity of the NuMA gene as well as to provide a physical map of the restriction
sites within the gene. High resolution in situ hybridization was used to assess position
of the NuMA gene in the human genome and copy number.
II I!I FIG. 4. NuMA Northern blot. ME180 cervical carcinoma cell poly A+ RNA
(20ug/well) was probed with clones TPR-NMP1 (left) and NuMA-NMP4 (right)
radio labeled with 32p-dCTP by PCR direction incorporation. Position of 28s and 
ribosomal RNA are indicated by the upper and lower arrows respectively.
204.41
.. -_.
Genomic Southern blot analysis with NuMA cDNA probes A4 and NMP8 resulted in 
simple pattern of one or two bands ranging from 7 to 13 kb in 
size using high
stringency post-hybridization washing conditions (O.
5XSSC/O.5%SDS final wash)
c.onsistent with the presence of a single copy gene (Figure 5, (43)). The number of
sites cut for each restriction enzyme such as Xbal were in agreement with the sites
predicted by the published cDNA sequence. Eco RI and Bam HI digests each produced two
bands(seen better on long exposure) however, indicating restriction sites in the gene
which are not in the cDNA. Therefore , intervening sequences are probably present in
the region of the NuMA gene recognized by the cDNA probes indicating splicing of a
primary transcript.
High resolution in situ hybridization was performed with the NuMA cDNA and human
metaphase chromosomes. The NuMA cDNA was found to hybridize consistently at a single
locus on a metacentric C-group chromosome (Figure 6A,B). Both sister chromatids
generally showed label, confirming bona fide hybridization. Hybridization of this
relatively small (2.5 kb) probe was detected without amplification or image
processing. The majority of cells showed one labeled chromosome, and approximately
one-third of cells showed two labeled homologous chromosomes. Signal was not observed
on any other chromosomes. Cells in interphase most often gave single hybridization
signals (data not shown). Within the limits of resolution of this technique , these results
indicate that NuMA is a singe copy gene.
To identify the chromosome and regional position of the gene , banding analysis was
employed using DAPI staining. The NuMA gene was localized to chromosome 11 based on
screening 62 banded metaphase spreads (2 examples shown in Figure 6A,B). The
position of the NuMA gene was determined by evaluating 25 chromosomes for signal
:; ....
11.
.. --
0 ...
FIG. 5. Southern blot. For analysis of the NuMA gene in total
genomic DNA, ME180 cervical carcinoma cell DNA (10ug/well)
was restriction digested with various enzymes and Southern
blotted. Probes were labeled by random primed DNA synthesis
with incorporation of digoxygenin dUTP. Results were
visualized by non- isotopic chemiluminescence (BMB).
'..,---- ----
FIG. 6. Localization of the NuMA gene by fluorescence in situ
hybridization. (A B) Two examples of the NuMA cDNA hybridized to human
chromosome 11. The FITC signal is on the top and the DAPI banded chromosome is on
the bottom. Arrow indicates location of signals and corresponding chromosomes. (C)
Idiogram of human chromosome 11 showing placement of the NuMA gene in 11q13
based on analysis of 10 banded metaphase chromosomes. Measurement of signal
placement in 15 additional metaphase spreads agreed with this localization.
placement with respect to chromosome bands as well as total chromosome length
(Figure 6A C). These results indicated that the NuMA gene is localized to band q13 on
chromosome 11. The results from ten evaluations were summarized on the idiogram in
Figure 6C. Taken together , the Southern analysis and in situ hybridization demonstrated
that the gene for NuMA appears to be a single locus gene located on human chromosome
11q13 (83).
D. Identiication of alternatively spliced mRNA isoforms
The cDNA probes for NuMA reacted with multiple mRNA bands in Northern analysis. In
situ hybridization and Southern analysis detected a single NuMA gene indicating that
these forms of mRNA may be transcribed from the same gene. Further evidence for
spliced mRNA isoforms was as follows. In the course of library screening, one cDNA
clone was isolated that contained a potential splice site followed by novel sequence
information (Figure 7A). The clone NMP 8 when sequenced at the 3' end revealed"408
bp of novel sequence with a translational termination site that could account for a
truncated version of the NuMA protein with 23 novel amino acids in the C- terminus
(Figure 7B). The point of divergence between the published sequence and the novel
sequence was at a consensus splice sequence (AG' GT, Figure 7A). The 408 bp sequence
was searched against Genbank and shared no homology to any known sequence. A
restriction map for NMP 8 also revealed an Eco RV site in this region which was not
present in the published NuMA sequence (data not shown, Figure 7 A , 204.41.seq
position 2103). Another interesting splice sequence was isolated during PCR analysis
(Figure 7C, discussed below).
To confirm the presence of alternatively spliced mRNA in the total mRNA from human
cells, PCR analysis was done with NuMA primers (Figure 8) and RNA or DNA from
FIG. 7. Sequence of RNA isoforms. (A) The 3' end of NuMA's clone NMP 8 was
aligned to the published full length cDNA from Yang (42) revealing a novel 408 bp
sequence. A consensus splice sequence is at Yang position 5432. (B) Analysis of the
predicted amino acid sequence of NMP 8 demonstrates that this isoform would translate
24 novel amino acids. (C) Sequence of clone pCS7 , another putative alternatively spliced
mRNA.
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FIG. 7. Sequence of RNA isoforms (cont.
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FIG. 8. Oligonucleotide primers for NuMA. This schematic
ilustrates the position on the cDNA and sequence of all primers
used in sequencing and subsequent PCR analysis.
III
human cells. ME180 poly A+ mRNA was oligo dT primed and reverse 
transcribed into
eDNA. This cDNA was used as a template in PCR amplification using 
primers
(ASP/204AL2, Figure 8) that bracket the potential splice site described in 
Figure 7.
The ampliication resulted in the expected band of 510 bp based on the sequence in
Figure 7 and an upper band of 630 bp (Figure 9A, lane 3). These PCR products were
subCloned into a T A cloning vector and sequenced. The sequence of the smaller band (lane
3) was identical to the 3' end of the NMP8 clone (lane 1), confirming the presence of
the RNA isoform in cells. This subclone was termed pCS2.
The larger amplification product contained 120 bp of novel sequence on the 5' end,
bracketed by a consensus splice sequence (lane 3 and Figure 7C). This construct was
named pCS7. To test whether the pCS7 sequence was part of the gene or an artifact, the
same PCR primer pair, ASP/204AL2, was used to amplify a band from total 
human
genomic DNA. This resulted in a 630 bp product corresponding to the pCS7 insert (lane
9). Ampliication of RNA by rt-PCR using primers that bracket the C-
terminus of
NuMA produced 3-4 bands suggesting that at least 3 mRNA isoforms may exist (Figure
9B). This was confirmed by other studies (431. The alternatively spliced mRNA data
were summarized in schematic form in Figure 10.
As a final confirmation of the presence of alternatively spliced forms of NuMA RNA and
to obtain further insight into how the spliced mRNA is produced, the cloned splice
sequences were labeled and used in Northern analysis with ME180 poly A+ RNA
(Figure 11). The splice sequence detected the upper band of approximately 8.
0 kb and a
lower 3.0 kb band, while a probe to a conserved region detected the 8.
0 kb band as well
as the major 7.2 kb band. These experiments demonstrated that the splice sequence may
be derived from the lower abundance 8.0 kb transcript and perhaps a smaller 3.
0 kb
. H
III.!
II!
III
r I III 
FIG. 9. PCR analysis of RNA isoforms. (A) ME180 poly A+ RNA was reverse
transcribed into cDNA and amplified with primers bracketing the potential splice site
or primers to the sequence at the 3' end of NMP 8. PCR products were separated on
ethidium bromide stained gels and photographed. (B) PCR ampliication of total
cDNA' s with primers bracketing the 3' end of NuMA.
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FIG. 10. Summary of RNA isoform analysis. Schematic of all NuMA sequences
identified thus far. Variable regions are excised out as triangles and sizes are in base
pair.
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FIG. 11. Northern analysis of RNA isoforms. 15 ug of ME180 Poly A+ RNA was
probed with radiolabeled probes to various regions of the NuMA cDNA. Left lane - probe is to a
conserved region , NMP4; Middle lane - probe is to the 3' end of the published NuMA cDNA;
Right lane - probe is to the novel splice sequence. The splice sequence detects the low
abundance larger RNA isoform.
form but not the major 7.2 kb transcript. In summary, there was one major NuMA
transcript of 7.2 kb that was represented in the published cDNA sequence. In addition,
several NuMA mRNA isoforms were expressed in the cell. One isoform was represented
in an 8.0 kb transcript.
E. Discussion
The goal of this study was to identify a resident protein component of the nuclear matrix
using molecular cloning techniques to isolate and sequence the corresponding cDNA. Once
NuMA was discovered, the cDNA became a molecular tool to probe the gene and mRNA to
obtain information about the nature of this nuclear matrix protein. From the amino acid
sequence, the protein was predicted to be a 1485 amino acid coiled-coil dimer that
would form a 200 nm central rod domain (42). With this in mind, a pressing question
is whether NuMA can form these filamentous structures and whether these structures
contribute to the fibrillogranular network of the nuclear matrix seen in electron
microscopy (Figure 1).
While these are difficult questions to answer , there are several pieces of evidence that
support this hypothesis. First, immunogold electron microscopy localized NuMA to the
fibrillogranular network of the nuclear matrix (54). Second, negative stain electron
microscopy of purified full length fusion protein gave a filamentous structure (84).
Third, an in depth computer analysis suggested the possibility of head-to- tail
aggregation of NuMA based on possible interaction of the acidic head domain with the
basic tail domain after dimerization, thereby creating a loose meshwork not unlike the
nuclear matrix (85). How these conformations of NuMA would contribute to the
structure and stabilty of the mitotic spindle is less clear.
During the cloning and characterization of NuMA, several significant observations were
made about the gene and messenger RNA. First, using the sensitive technique of in situ
hybridization, the NuMA gene was localized to human chromosome 11 q13 (Figure 6).
Cancer related aberrations in chromosome 11 q13 site have been described and are
varied, ranging from deletions and translocations to DNA amplifications (86).
Chromosome 11 q13 has long been recognized as a folate-sensitive fragile site, FRA 11 A
(87), a site that in response to environmental factors can be damaged leading to
tumorigenesis. Cyclin D, INT2, and HSTF1 have been mapped to 11q13 and have been
linked to esophageal and breast cancer, defined by a general amplification of the DNA in
that area (88). These observations have led to the idea that chromosome 11 q13 may
contain cell cycle genes involved in tumorigenesis in certain cancer types (89).
Although NuMA may not participate in this proposed mechanism for tumorigenesis, the
observation that the NuMA gene localizes to chromosome 11 q13 raises some interesting
possible roles for the protein. For example. overexpressionof NuMA could contribute to
the acceleration of proliferation if it were normally found in limiting quantities in the
cell.
NuMA has a complex mRNA expression profie with interesting functional implications.
Northern analysis with a 600 bp partial cDNA detected a major transcript of 7.2 kb and
a less abundant transcript of -8.0 kb. As previously discussed, these transcripts
appeared to arise from a single gene. While screening libraries, one of the cDNA clones
was found to contain a variation in the sequence at the 3' end (Figure 7A). This
variation was not a library artifact (common in Agt11 libraries) but an actual isoform
of NuMA mRNA based on the following evidence. First, the sequence variation began with
a consensus AG'GT splice site and a EcoRV restriction site (Figure 7)not found in the
published cDNA but confirmed by Southern blot analysis (Figure 5). Second, the PCR
analysis showed that this isoform sequence exists in the mRNA of cells (Figure 9A, lane
3) and in the gene (Figure 9A , lane 9). Finally, Northern analysis using probes
specific to spliced regions showed that the isoform is likely to be the larger and low
abundance 8.0 kb NuMA mRNA (Figure 11 , right lane). It must be noted that the 8.0 kb
message may be unspliced RNA. Unspliced RNA for some messages can be carried in a
poly A+ RNA selection procedure that starts with total RNA. NuMA pre-mRNA may be
present and future studies should attempt to resolve this issue by examining
cytoplasmic RNA or specific proteins produced from the alternatively spliced
transcripts to validate these transcripts. The results, however , suggest that there is an
isoform of NuMA mRNA that is produced by alternative splicing from one NuMA gene and
is expressed as an 8.0 kb transcript.
The expression profile for NuMA mRNAs is summarized in Figure 10. There are three
variations in the 3' end of NuMA mRNA identified thus far. T33 was the proposed 3' end
of the major 7.2 kb transcript. U6/NMP8 was the 3' end of the -8.0 kb transcript and
U4 was a third variation. Tang and co-workers predicted that the U4 and U6 isoforms
produce truncated versions of the protein at sizes of 194 and 196 kDa respectively,
based on proteins detected in immunoprecipitation experiments (43). These may be
overinterpretations for the following reasons. The first is that there has been 
analysis of variations of NuMA mRNAs in the 5' end. In fact, there has been litte
analysis of the first 5000 bases of NuMA mRNA. There is no information about the
sequence of the NuMA gene other than the minor PCR analysis done in this study. This
study indicates that there are other varied regions (Figure 7C) not detected by Tang and
colleagues. Without information about the full length transcripts for the isoforms and
the gene that encoded them, definitive statements can not be made about what the
proteins wil be if produced from them. Secondly, it is unclear whether the U4/U6
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isoforms produce proteins of 194 and 196 kDa detected by Tang and colleagues (43) or
whether they are due to protein degradation. There are degradation products that plague
most NuMA protein analyses (which wil be discussed further in Chapter 4) and can
lead to misinterpretation of the NuMA protein profile.
Without the ability to correlate the RNA isoforms with actual proteins, it is difficult to
assess the functional significance of the alternative splicing. However, there was one
subsequent observation from Tang et at. worth noting. These workers recently prepared
expression constructs by fusing the variable 3' ends to the major transcript (assuming
that this was the in vivo isoform) at the splice site (position 5155, (42)).
Overexpression of the U4 and U6 constructs resulted in localization to interphase
centrosomes. As NuMA oscilated between the nucleus and centrosome (see below,
Chapter 4), this was an interesting result. Tang proposed that these are forms of NuMA
that are resident centrosome components in normal cells. The significance of this
observation wil be discussed in Chapter 6.
CHAPTER 4
CHARACTERIZATION OF NUMA PROTEIN
Of all the antibodies raised to nuclear matrix proteins, the monoclonal antibody 204.41
was chosen as a research tool as it gave a distinctive distribution pattern in the cell by
immunofluorescence microscopy. In most cells, it was predictably nuclear. But in
dividing cells, it redistributed to the spindle poles. This was intriguing as it suggested
that this nuclear matrix protein also functioned during cell division. In this chapter
NuMA was examined in greater detail at the protein level. The experimental strategy
was to use the NuMA antibodies to scrutinize the subcellular localization of NuMA in all
phases of the cell cycle and to characterize the protein biochemically in a series of
immunoprecipitation experiments. These experiments examined the nature of the
protein with respect to its size, degree of conservation, and phosphorylation state.
Obtaining this information about NuMA could enrich our understanding of the function of
NuMA in the nucleus or the mitotic spindle and could contribute to our knowledge of
mitotic and other nuclear processes.
The changes in NuMA's locations in the cell could be explained in several ways. It is
possible that different isoforms of NuMA exist at different places in the cell.
Alternatively, one protein may exist but be regulated by modifications such as
phosphorylation. To address these possibilities, a biochemical characterization was
performed to assess the size and phosphorylation state of the protein , as well as to
identify any isoforms. In addition , these studies could potentially contribute to the our
understanding of alternatively spliced RNA isoforms. There is more than one RNA
isoform (43), so it was of interest to see if there are corresponding protein isoforms
synthesized in the cell that were detectable with our antibodies.
There are other interesting properties of NuMA that could be examined biochemically.
Whether NuMA is a highly conserved protein could be investigated by screening for the
protein in Western blot analyses of protein preparations from various species. If the
protein was highly conserved, then the function of the protein could be significant if not
essential. The degree of conservation of the protein would also be useful in designing
future experiments. For example, if cell cycle studies were to be conducted, some cell
types would be easier to synchronize than others.
From these observations, several important questions could be asked about the nature of
the protein. 1) What is the function of the protein through the cell cycle? 2) What
specifies the localization of NuMA to the spindle pole? 3) What regulates the change in
distribution? 4) What are its binding partners? 5) Are there cells that have no NuMA
and what is that phenotype? Answering these questions may contribute to understanding
the function of NuMA in the cell (e.g. if the function of a binding partner is known) and
how it is regulated (phosphorylation).
Resu Its
A. Subcellular distribution through the cell cycle
The antibody 204.41 was used in immunofluorescence staining experiments with
several human cell lines. Results obtained with MCF-7, a human breast carcinoma line,
are depicted in Figure 12. In interphase cells, NuMA is localized throughout the
nuclear interior in a punctate pattern and was excluded from nucleoli (A B). During
early prophase, the nuclear staining gradually decreases (Panels D, F) until metaphase,
where staining is observed at the polar region of the spindle apparatus (close to the
centrosomes, Figure 12 , Panels Hand J). Centrioles are not stained as seen in panel H
where an end-on view of the metaphase plate shows star- like staining with a clear
center. The star-shaped spindle structure appears to be composed of approximately 10
separate microtubule arms. A side view of the metaphase plate indicates staining on both
spindle poles (Panel J). As the cells divide, the proteins redistribute to the newly
developing nuclei until telophase where the punctate intranuclear staining is restored
(Panels L- P).
FIG 12. Distribution of NuMA during the cell cycle. Indirect
immunofluorescence microscopy of MCF7 breast carcinoma cells was performed with
the NuMA monoclonal antibody and an FITC conjugated secondary antibody.
Corresponding DNA in each field is on the left stained with DAPI. Phases of the cell
cycle were as follows: interphase (A B), early prophase (C,
D), late prophase (E F),
metaphase (G-J), anaphase (K L), early telophase (M N), late telophase (O, P). Cell
, I
H is an end on view of one spindle pole. Celll-J is a side view of both spindle poles.
Note the lack of NuMA staining at the centrioles indicated by the dark central hole
(Panel H). Bar 5 um.
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FIG 12. Distribution of NuMA during the cell cycle (cont.
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B. Variations on the distribution of NuMA
Most immunofluorescence experimental protocols used in this study involved extraction
of a cell with Triton buffer before fixing the samples with paraformaldehyde or
methanol. These methods removed much of the soluble protein and lipid prior to fixation
and staining. To ilustrate the variation in patterns of NuMA localization or 
background
seen with NuMA antibodies, samples were prepared without extraction prior to fixation.
Figure 13A is an ME180 cell that has been fixed in methanol without prior extraction.
There is a diffuse cytoplasmic signal as well as the typical 
punctate nuclear staining.
CHO cells have a faint, somewhat vesicular stain in the 
cytoplasm (Figure 13B). The
CHO cell nuclei are also stained with DAPi to visualize the DNA.
In a preliminary study with Dr. Richard Jack at Harvard University, NuMA was
examined in a terminally differentiated cell system, the 
human granulocyte system.
First, the subcellular distribution of NuMA was examined in the progenitor cell, the
premyeloblast. The tissue culture cell line HL-60 was employed as these cells are
premyeloblasts and can be induced to form either monocytes or neutrophils with the
appropriate agents. First the DNA was stained with DAPi to identify the nuclei (Figure
13C). Next, the HL-60 were stained with NuMA antibodies and gave the expected
nuclear distribution of NuMA (Figure 13D) excluded from nucleoli. In neutrophils, the
nuclei are condensed and multi- lobed, illustrated in Figure 13E using DAPi stain. In
granulocyte cell preparations, which contain 99.5% neutrophils and 
eosinophils (R.
Jack, personal communication), NuMA is absent from the nuclei (Figure 13F) although
there is some cytoplasmic background signal. Eosinophils were found in the same
preparation (not shown) and did not appear to contain any nuclear or cytoplasmic
NuMA. This preliminary study shows that NuMA may be downregulated in the
differentiation pathway of granulocytes.
111,
11'II 
1111 , FIG 13. Variations in NuMA subcellular distribution. Indirect
immunofluorescence microscopy of cells with atypical NuMA staining patterns. (A)
an unextracted, methanol fixed ME180 human cervical carcinoma cell and (B) an
i I
unextracted, methanol fixed CHO cell stained with the NuMA 204.41 antibody
showing cytoplasmic background staining. The CHO cell is also stained with DAPi to
show the DNA in the nucleus. (C,D) HL-60 human premyeloleukemic cells stained
with DAPi to visualize DNA in blue (C) and NuMA antibody 204.41 to show NuMA
distribution in the nucleus in green (D). These cells can be induced to differentiate
!I '
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into neutrophils (E , here purified from human blood) in which nuclei become
multi-lobed (E , DAPi-blue) and appear to exclude NuMA (F , NuMA-green). Bar 5
um.
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c. Biochemical characterization of the protein
The NuMA monoclonal antibody 204.41 was used in Western blot analyses and detected a
protein of -250 kDa molecular weight in total protein extracts from CHO cells (Figure
14). It was the only band detected using all NuMA antibodies. The same was true for
NuMA in other mammalian species. There was one major band at approximately 250
kDa in mouse, hamster , and human (Figure 15). The protein was not detected in
Xenopus laevis total protein extracts (Figure 15) with any of the NuMA antibodies (the
204.41 monoclonal shown here). In some samples, more than one band reacted with
anti-NuMA antibodies but the lower molecular weight bands are most likely due to
protein degradation (see discussion). In most of the biochemical analyses, antibodies to
several different proteins were used as controls. The antibody used most often was to
pericentrin, a highly conserved protein of the centrosome (72). These studies were
done in collaboration with Dr. Stephen Doxsey (UMass Medical Center , Worcester , MA).
Pericentrin was readily detectable in extracts from most species examined. Pericentrin
appeared to be a doublet of approximately 250 and 300 kDa of varied intensities in
mammalian cells (Figure 15).
The next analysis of NuMA involved testing the monoclonal (204.41/107.7) and
polyclonal antibodies for the abilty to immunoprecipitate the protein from cell Iysates.
NuMA was immunoprecipitated cleanly as a single band from whole cell extracts
(Figure 16A , right). Pericentrin antibodies immunoprecipitated two polypeptides
(Figure 16A, left) similar to those seen in Western blots. The small bands at
approximately 60 kDa were the rabbit immunoglobulin bands that were detected by the
secondary antibodies (Figure 16, left). To test whether there were any co-
precipitating proteins that were not detected by Western blot analysis,
FIG. 14. NuMA Western blot. 20 ug of CHO cell protein extract was subjected
to SDS-PAGE on 5% gels and blotted onto Immobilon- P. Blots were probed with
the NuMA monclonal antibody 204.41 and detected with a secondary goat anti-
mouse alkaline phosphatase conjugated antibody followed by exposure to
chemiluminescent substrate and autoradiography.
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FIG. 15. NuMA Zoo Western blot. 20 ug of protein extract from 
hamster(CHO
cells), Xenopus(oocytes), mouse (3T3 cells), and human (ME180 cells) was Western
blotted and probed for NuMA with the 204.41 monoclonal antibody or with a pericentrin
polyclonal antibody. Molecular weight markers are in kDa.
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FIG. 16. NuMA immunoprecipitation. (A) NuMA and pericentrin were
immunoprecipitated with polyclonal antibodies to each protein from total CHO 
3T3 protein extracts and analyzed by Western blot with the monoclonal antibody
204.41 for NuMA or the pericentrin polyclonal antibody. (B) NuMA was
immunoprecipitated out of CHO extracts after metabolic labeling with 35S-
methionine and analyzed by SDS-PAGE. Gels were dried and autoradiographed. Lane
1 - total extract; lane 2 - beads alone; lane 3 - NuMA polyclonal
immunoprecipitation; lane 4 - NuMA monoclonal immunoprecipitation.
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200 kDa
immunoprecipitations were done with extracts from cells that had been labeled with
35S-methionine. NuMA antibodies precipitated a single, major protein (Figure 16B).
D. Phosphorylation of NuMA.
The phosphorylation state of NuMA was examined by immunoprecipitation from extracts
of log- phase cells that were labeled for four hours with P-orthophosphate. As shown
in Figure 17 A , NuMA is immunoprecipitated as a single phosphoprotein band with the
expected molecular weight of 250 kDa (lane 1). When a phosphatase inhibitor cocktail
was included in the lysis buffer (90), a second phosphoprotein was detected (Figure
17B, lanes 4 5) at approximately 180 kDa in the NuMA immunoprecipitations. A
similar co-precipitating protein was seen in pericentrin immunoprecipitates (lanes
3) but not in TPR immunoprecipitates (lane 1). NuMA's identity was confirmed by
subsequent Western analysis of lane 4 from Figure 17B (Figure 17C, lane 1). In
summary, this work demonstrated that NuMA and pericentrin are phosphorylated in
log-phase cells and may interact with another phosphoprotein of 180 kDa whose
identity is unknown.
E. Identiication of an electrophoretic mobility shift in mitotic NuMA
The mitotic phosphorylation state of NuMA was initially determined in vivo by 32p-
orthophosphate labeling and immunoprecipitation. In interphase cells, the 250 kDa
phosphoprotein was resolved on SDS- PAGE after autoradiography (Figure 18, lane I).
In addition, the phosphoprotein of approximately 180 kDa coprecipitated with NuMA
(Figure 18, asterisk). In mitotic cells labeled with 32P-orthophosphate, NuMA
appeared as a broader band of higher molecular weight than in interphase cells (lane
M). Interestingly, the 180 kDa protein did not coprecipitate with NuMA in extracts
prepared from mitotic cells.
FIG 17. NuMA is a phosphoprotein. (A. 1 ) NuMA was immunoprecipitated with
the polyclonal antibody from CHO extracts after labeling with 32p
, separated on 5%
polyacrylamide gels , blotted and autoradiographed. Lane 2 is the supernatant. (B)
Inclusion of specific phosphatase inhibitors resulted in the detection of a co-
precipitating protein with NuMA (lanes 4 5) and pericentrin (lanes 2 3) that ran at
-180 kDa. This band was absent from an immunoprecipitation of TPR (lane 1) from
32P- labeled ME180 protein extracts. Lanes 2 and 4 are immunoprecipitations from
32P- labeled 3T3 protein extracts. Lanes 3 and 5 are immunoprecipitations from
II 
32P- labeled CHO protein extracts. Lane 6 is the supernatant 
from the 32P- labeled
3T3 protein extracts. Lane 7 is the supernatant from the 32P- labeled CHO protein
extracts. (C) This 180 kDa band did not cross react with the NuMA 
antibody in
subsequent Western blot analysis (Jane 1). Lane C2 is the 32p signal with a longer
exposure of lane BA. Molecular weight markers are in kDa.
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FIG. 18. Immunoprecipitation of NuMA from cells labeled with 32P-
orthophosphate. Protein extracts were prepared from interphase (I) and mitotic
(M) CHO cells in the presence of 32p-orthophosphoric acid. NuMA was
immunoprecipitated , run out on 5% polyacrylamide gels , transferred onto
Immobilon-P membranes and subjected to autoradiography. Arrows indicate
electrophoretic shift in mobility of mitotic NuMA. Asterisk (*) indicates 180kd co-
precipitating protein from interphase extracts. Molecular mass standards are
indicated in kDa.
To determine whether the mobility shift seen in mitosis was due to phosphorylation,
immunoprecipitates from unlabeled cells were treated with alkaline phosphatase and
Western blotted (Figure 19). Following optimization of the gel system for the
resolution of the high molecular weight species (see Materials and Methods), alkaline
phosphatase treatment demonstrated that the shifted mitotic protein was reduced to
interphase mobility (lanes 2 and 4). Inclusion of phosphatase inhibitors in the
preparation prevented the shift down to interphase mobility (lane 6) and controlled for
contaminating proteolytic activity in the phosphatase preparation. The phosphatase
sensitivity of NuMA demonstrated that the change in the electrophoretic mobility was
the result of phosphorylation. The fact that the electrophoretic mobility of interphase
NuMA was unaffected it's phosphorylation state or subsequent phosphatase treatment
(Figure 19, lanes 1 and 3) made it possible to study the mitosis-specific
phosphorylation of NuMA in unlabeled cells in future experiments.
F. Discussion
The biochemical and morphological work on NuMA in this chapter defined some
properties of the protein that may have major implications for its cellular function.
Using the antibodies as probes, the protein was examined in the cell by indirect
immunofluorescence microscopy through the cell cycle as well as in various
biochemical analyses to characterize the size, conservation, subcellular distribution,
and post-translational modifications. From these results, several observations have
been made that contribute to our understanding of NuMA.
This immunofluorescence study identified a cell type that appeared to contain no NuMA
in its nucleus(Figure 13F). These cells are human neutrophils that were fixed in
methanol and stained with NuMA antibodies. Neutrophils arise from a well characterized
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FIG. 19. Phosphatase sensitivity of NuMA. NuMA immunoprecipitates from
interphase (I) and mitotic (M) CHO cells were treated under various conditions , run
on SDS gels, transferred to Immobilon , and detected by chemiluminescence. Lanes 
and 2 , untreated samples; 3 and 4 , alkaline phosphatase-treated; 5 and 6, treated
with alkaline phosphatase in the presence of phosphatase inhibitors. Molecular mass
standards are indicated in kDa.
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differentiation pathway starting with premyeloblasts (dividing cells with round nuclei)
and ending with terminally differentiated polymorphonuclear cells (91). These cells
had nuclei with distinctively lobed shapes. They were also most-mitotic. Given NuMA'
proposed role in nuclear and spindle stabilty, it was interesting that a cell that had an
unusual nuclear shape and no longer assembled mitotic spindles, would lack NuMA. It is
possible that NuMA may be excluded from the final nuclei that reform during the last
mitosis of these cells. An alternative explanation is that NuMA could be downregulated at
a specific stage in the differentiation pathway for neutrophils. A system such as the HL-
60 cell line (92) should prove useful for examining these changes in NuMA'
distribution as well as the mechanisms by which these changes occur. These studies may
provide insights into the function of NuMA.
Western blot analyses consistently showed NuMA to be a single band (Figure 14).
However, two studies by other groups showed multiple bands on NuMA Western blots
(39, 43). One study claimed that a lower band was an isoform of NuMA that co localized
to domains enriched in splicing components (48). It is possible that this "NuMA
isoform" may be authentic, but to date, no other investigations could corroborate these
findings. Another study claimed that the lower band may have been derived from
alternatively spliced NuMA RNAs (see Chapter 6, (471). This has not been directly
demonstrated. Most studies found that the multiple bands would appear if the protein
extract had undergone degradation (data not shown, (35, 37, 40 , 44 , 471).
Probing a\Nestern blot of total protein from a variety of species resulted in detection of
mammalian NuMA only (Figure 15). It is possible that there is no NuMA homologue in
nonmammalian species such as Xenopus, but this is unlikely given that one group may
have cloned the Xenopus homologue (Cleveland group, see (53)). It is more likely that
r' 
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the antibodies used in this study do not cross react with nonmammalian NuMA protein. It
wil be important to identify NuMA homologues in other species, especially ones
amenable of genetic manipulations (such as yeast), in order to define a function for the
protein.
NuMA was isolated as a phosphoprotein (Figure 17). What was surprising about this
work was the co-precipitation of another phosphoprotein (Figure 17B, lane 4,
(34)). This phosphoprotein was -180 kDa and a similar protein appeared with
pericentrin as well but was absent from the TPR lane. It was unlikely that the 180 kDa
protein was a breakdown product of NuMA since this protein was not detected in
Western analyses (Figure 17C, lane 1) or when phosphatase inhibitors were omitted
(Figure 17A, lane 1). This work demonstrated that NuMA is a phosphoprotein in log-
phase cells and leads into an examination of the phosphorylation of NuMA through the
cell cycle (Chapter 5).
In examining NuMA from interphase and mitotic cells, there was a 
phosphorylation-
induced shift in electrophoretic mobilty in mitotic NuMA (Figures 18 and 19). The
mitosis-specific phosphorylation events described here had previously gone unnoticed
(40 , 43. 93), probably due to technical difficulties associated with detection of the
phosphorylation-induced shift in electrophoretic mobility. Changes in the 
mobility of
mitotic NuMA have been confirmed recently (53). Such shifts in electrophoretic
mobility occur in many (94, 95), but not all (65), phosphoproteins. Although it has
, been hypothesized that the addition of phosphate affects charge or tertiary structure,
even under conditions of SDS-PAGE, the cause of the shifts remains unclear 
(94). Other
conditions can alter a proteins mobiliy on SDS-PAGE such as overloading a lane or
varying the salt concentration between lanes, however this study carefully avoided such
conditions.
CHAPTER 5
CHARACTERIZATION OF PHOSPHORYLATION OF NUMA THROUGH THE CELL
CYCLE
NuMA is a component of the nuclear matrix (Chapter 3) that redistributes to the
spindle poles at mitosis (Chapter 4). While the function of NuMA is not known, it has
been implicated in spindle organization during mitosis and nuclear reformation.
Phosphorylation is thought to playa regulatory role in NuMA function (34, 42, 53). In
the work presented in Chapter 4 , NuMA is shown to be a phosphoprotein that undergoes
mitosis-specific phosphorylation events. The work in this chapter takes this
observation and expands it by examining the phosphorylation of NuMA throughout the
cell cycle using highly synchronized cells. The experimental strategy involves isolating
populations of synchronized cells to obtain a careful temporal analysis of NuMA'
phosphorylation state during its changing subcellular distribution.
When studying protein phosphorylation , one of the first questions to ask is which kinase
acts on the protein, and then to determine which signal transduction pathway regulates
the protein. A simple way to propose a candidate kinase is to find a temporal correlation
of phosphorylation with known active kinases. This study carefully examines when and
where the phosphorylation of NuMA occurs to try to find a pattern that correlates with
the activity of a known mitotic kinase (such as cdc2 kinase at the mitotic spindle). By
examining known substrates for kinases such as lamin B for cdc2 kinase while
examining NuMA's phosphorylation pattern may provide clues to the identity of the
kinase that regulates NuMA at mitosis.
Another important question to address has to do with the functional consequence of this
mitotic phosphorylation. Does the phosphorylation correlate to changes in the protein
subcellular distribution? Does it change NuMA's binding partners? Do properties such
as solubility fJf the protein change in response to these events? Answers to these
questions wil contribute to understanding of how NuMA interacts with the nucleus and
mitotic spindle as well as how proteins are regulated at mitosis.
The work in this chapter demonstrates that NuMA undergoes multiple phosphorylation
events with similar timing to lamin B phosphorylation. The mitotic phosphorylation did
not require spindle formation or correlate with a change in the protein s solubility.
Dephosphorylation of NuMA occurred in two distinct steps, after lamin B assembled into
the nuclear lamina in early G1 and at the end of G1 . Based on the timing of the
phosphorylation and dephosphorylation observed in this study, it is proposed that these
events may playa role in aspects of the nucleus such as nuclear organization,
transcription, or initiation of DNA replication at G1/S.
RESUL TS
A. Relationship of phosphorylation to spindle association.
The timing of NuMA's mitotic phosphorylation was consistent with its release from the
nucleus as cells entered mitosis. In fact, it was strikingly similar to the
phosphorylation-dependent disassembly of lamin B from the nuclear lamina (65).
However , it was also possible that the phosphorylation of NuMA occurred when it
redistributed to the mitotic spindle. To determine whether NuMA'
s mitotic
phosphorylation was the result of its association with the spindle apparatus, the
phosphorylation state of the protein was examined in nocodazole-treated cells in which
microtubule spindle formation was prevented and cells were arrested cells in
prometaphase (80). NuMA was phosphorylated (Figure 20, lane N) to the same level 
in metaphase cells with intact spindles (lane M) indicated by the consistent presence of
bands with equivalent electrophoretic mobilities. In addition , a previously undetected
doublet was resolved in both cases indicating that multiple phosphorylatio
events had
occurred. These data demonstrated that NuMA did not require spindle formation to
undergo these mitotic phosphorylation events and indicated that the phosphorylation
occurred prior to spindle assembly in metaphase, while NuMA was still in the 
nucleus.
To ensure that the mitotic spindles were disrupted by nocodazole treatment and to
determine where NuMA was located under these conditions, immunofluorescence
microscopy was performed with NuMA and pericentrin antibodies. In non-drug treated
mitotic cells, normal microtubule spindles were observed (shown in Figure 24B).
NuMA and pericentrin were located at the spindle poles, and chromosomes were aligned
on the metaphase plate (Figure 21 A). In nocodazole-treated mitotic cells, the majority
of NuMA was dispersed throughout the cell (Figure 21 B), and no microtubule spindles
were detected (Figure 21 C). NuMA was also found in a variable number of foci
randomly arranged in the cytoplasm and near chromosomes and centrosomes (Figure
21 B, (37, 45)). Taken together, the biochemical and morphological data demonstrated
that phosphorylation of NuMA occurred independently of its association with the spindle
apparatus.
"' ! '- '--
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FIG. 20. NuMA phosphorylation in the absence of spindles. NuMA was
immunoprecipitated from extracts prepared from interphase CHO cells (I), cells
prepared by mitotic shake-off (M) and nocodazole-treated mitotic cells (N).
Samples were blotted and probed. Molecular mass standards are indicated in kDa.
FIG. 21. NuMA localization in the absence 
of spindles. Cells were triple
stained with a monoclonal antibody to pericentrin or tubulin (red), a 
polyclonal
antibody to NuMA (green), and with DAPI (DNA, blue). In nondrug- treated mitotic cells
(A) NuMA is centrosomal
, partially overlapping with pericentrin (indicated by yellow
signal). In nocodazole-treated mitotic cells (B), NuMA is largely cytoplasmic (green)
with several foci near centrosomes (defined by pericentrin-red) and chromosomes. In
nocodazole-treated mitotic cells stained with a tubulin 
antibody (red, panel C), no
microtubule spindle is formed and NuMA is overlapping tubulin signal throughout the
cell. Bar Sum.
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B. Cell cycle profile of phosphorylatio
To better understand the role of phosphorylation in NuMA localization and function, the
changes in the phosphorylation state of NuMA were carefully examined through the cell
cycle. To precisely correlate morphological and biochemical events during mitosis,
synchronized cell populations were used (Figure 22A). Quantitative analysis
demonstrated that a highly enriched population of mitotic cells (85%, Figure 22B)
progressed synchronously through telophase and into G1 (98%). These synchronous
populations were used to determine the phosphorylation state of NuMA (Figure 23) in
relation to its intracellular distribution (Figure 24).
The results from Figure 20 demonstrated that NuMA was phosphorylated prior to its
assembly onto the mitotic spindle suggesting that it had undergone phosphorylation
before metaphase. This implies that phosphorylatio occurs at prophase. It could,
however, have been a gradual event beginning in G2. To determine if NuMA underwent
this phosphorylation event in G2, NuMA from two different populations of G2 cells were
subjected to electrophoretic analysis for detection of shifted forms of the protein. In
Figure 23A, both G2 populations contained NuMA that migrated at the same position as
NuMA from interphase cells. Therefore, NuMA was phosphorylated after G2, in the
G2/M transition.
The synchronous cell populations described in Figure 22 were used to determine the
dephosphorylation of NuMA in relation to its intracellular distribution. NuMA'
metaphase phosphorylation state (Figure 23B, lane M) persisted through telophase
(Figure 23B, lane T) even though the protein redistributed from the spindle poles
(metaphase, Figure 24B) to the reforming nucleus at this time (Figure 24C), seen
with the exact same cells used in Figure 23. With NuMA still present in reforming
to - Metaphase t30 - Telophase
t60 - Gl
Phase 0 minutes 60 minutes
Metaphase 85. 1.0%
Anaphase 10.
Telophase
FIG. 22. Preparation of highly synchronized mitotic cells. (A)
Fluorescence micrographs of metaphase cells incubated in media for 0, 30, or 60
minutes (panels 1, 2, 3 respectively) at 370C. Cells were stained with a tubulin
monoclonal antibody (red), and DAPI (blue). Bar , 20 mm. (B) Quantitation of the
synchrony. More than 2000 cells were counted in five separate experiments and
results are summarized as the percent of cell population in each phase.
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FIG. 23. Phosphorylation profile of NuMA during the cell cycle. N u M A
was immunoprecipitated from cells at various stages of the cell cycle and Western
blotted. (A) Total protein extracts were prepared from chinese hamster cells
enriched for the G2 stage of the cell cycle. Lane 1. G2 cells(*) obtained from
populations double blocked with mimosine and VM26. Lane 2 - mitotic (nocodazole
blockedf cells; Lane 3 -G2 cells obtained after 8 hour release from mimosine block;
Lane 4 - interphase cells. (B). Cell cycle stages: (I), interphase cells in log phase,
1), previously frozen interphase cells , anaphase (t-10, A), telophase-t30 (T),
early G1-t60 (G1 E), and late G1-t240(G1 L). NuMA's downward shift in G1 E and
G 1 L is indicated by arrows 1 and 2. Three forms of NuMA were detected (three
dashes).Molecular mass standards are indicated in kDa.
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nuclei at early G1 (Figure 24D), the higher of the shifted bands became undetectable
(Figure 23B, lane G1 E), apparently shifting down to the intermediate mobility as a
result of dephosphorylation. Indeed, results from several experiments suggested that
the intermediate band increases in intensity as the upper band is lost. The
disappearance of the intermediate form occurred three hours later (Figure 23B, lane
G1 U and did not correlate with any changes in NuMA distribution or nuclear
morphology (Figure 24E).
Since the timing of NuMA phosphorylation and disassembly from the nucleus were
similar to lamin B (65), it seemed reasonable that the timing of dephosphorylation and
reassembly of the two proteins would also be similar. Using the synchronized cell
system (Figure 22), lamin B was distributed from the nucleus in interphase (Figure
25A), to the cytoplasm in mitosis (Figure 25B) and reassembled into the reforming
nuclear lamina starting at telophase (Figure 25C), an event previously shown to
require dephosphorylation (65, 67). Thus, lamin Band NuMA both assemble into
reforming nuclei at the same time. However, lamin B dephosphorylation correlated with
its reassembly while NuMA dephosphorylation did not. Instead, dephosphorylation
occurred in two separate events in G1.
C. Relationship of mitotic phosphorylation and solubility.
NuMA was originally identified based on its presence in the nuclear matrix. Therefore,
it should be an insoluble component of the nuclear fraction of a cell. Several previous
studies concluded that NuMA was not sensitive to extraction with Triton-X100 (39,
41). However, immunofluorescence studies through the cell cycle showed that the
protein relocalized to the mitotic spindle in the G2/M transition and back to the nucleus
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protein relocalized to the mitotic spindle in the 
G2/M transition and back to the nucleus
at telophase. This change in distribution suggests that NuMA may become soluble during
specific transitions. There is precedent for other nuclear proteins 
becoming soluble
during changes in their intracellular distribution. Lamin B undergoes 
mitotic-specific
phosphorylation that affects the protein s solubilty upon entry into mitosis 
(65). One
study found a soluble fraction of NuMA in mitotic cells (37). Thus, it seemed reasonable
that there would be a soluble form of NuMA at specific phases of the cell cycle.
To examine the solubilty changes in NuMA, total protein from cells synchronized at
telophase (T), early G1, and interphase (I) were separated into a Triton-soluble and
Triton- insoluble fractions. Cell equivalents of each extract were slot-
blotted onto nylon
membrane and probed with NuMA antibodies. There was a striking increase in the
soluble fraction in telophase cells (Figure 26A). The change in solubility was
quantitated in Table 3. At the beginning of telophase, when NuMA appears to leave the
spindle, the majority of the protein was Triton-soluble (54.7%). This result suggested
that NuMA was released from the spindle into the cytoplasm before 
reassembling into
nuclei. Support for this idea is shown in the insoluble fractions (Figure 26A) where
NuMA becomes increasingly insoluble as cells progress into G1 and later in interphase.
Since there was soluble NuMA at telophase, it became of interest to see if the soluble
form of the protein correlated with the phosphorylated forms (see Figure 23). Soluble
and insoluble fractions were Western blotted to examine solubility of the shifted formsof
NuMA. It was immediately apparent that the uppermost form (with slower
electrophoretic mobility) was completely segregated to the insoluble fraction while the
lower band was split between the soluble and insoluble fractions in telophase (Figure
A. Solubility Slot Blot 
Soluble
Insoluble
B. Solubility Shift Blot
Triton Soluble Triton Insoluble
pt-
200 kO-'
:"" ;:"
", 'it'
"''- - ::;." ,) .,. ,.,  . .
FIG. 26. NuMA has a soluble fraction. (A) Total CHO cell protein was slotted
onto immobilon-P at equal cell number amounts , through the cell cycle. Membranes
were analyzed by Western blot with the 204.41 NuMA monoclonal antibody and
chemiluminescent detection. (B) Total soluble and insoluble fractions were subjected
to analysis for the shifted forms of phosphorylated NuMA. Molecular weight markers
are in kDa.
TABLE 3 - Quantitation of Soluble NuMA. A) Western blots of NuMA'
soluble and insoluble fractions from 15 experiments were scanned into Photoshop
and subjected to densitometric analysis with Scan Analysis software. Relative
amounts are expressed as percentage of total NuMA at each stage of the cell cycle.
, I
B) graph illustrating changes in NuMA's solubilty.
, '
Table Quantitation Soluble NuMA the
Reforming Nucleus
act ophase
ase
Soluble 54. 7%+/- 16. 33. 9%+/- 16.
25. 3%+/- 18.
Insoluble 45. 3%+/- 16. 66. 1 %+/- 16.
74. 7%+/- 18.
Percent
100
-0 soluble
-- 
insoluble
Telophase Interphase
26B). This result demonstrated that there is no correlation between the mitosis-
specific phosphorylation events and changes in NuMA solubilty at 
mitosis.
NuMA became increasingly insoluble in cells from telophase to 
G1 (45.5 to 66.1%) and,
G1 to later interphase (66.1 to 74.7%, Figure 26 and Table 3). This 
insoluble fraction
contained both phosphorylated forms of NuMA (Figure 26B, Triton-
insoluble lane T),
thus showing no correlation to phosphorylation state. The final question addressed in
this study was whether NuMA had begun to reassociate with the reforming nuclear
matrix at these stages of the cell cycle. Nuclear matrix proteins were examined from
telophase (T), early G1, and interphase (I) cells by Western blot analysis 
(Figure
27A) and NuMA was found in all three stages. Thus, a fraction of insoluble NuMA was
part of the nuclear matrix as early as telophase. There was a formal possibility that the
telophase cells contained up to 14% G1 cell contaminants (Figure 22) which could have
provided the nuclear matrix signal. Therefore, as a control, the telophase cells were
spun onto coverslips and subjected to a nuclear matrix extraction procedure. These
cells were fixed and stained with NuMA and tubulin antibodies. The image in Figure 27B
demonstrates by immunofluorescence microscopy that NuMA was present in the
reforming nuclear matrix in telophase. The results of the solubilty study 
demonstrated
that in telophase when nuclear reformation begins, NuMA has both soluble and insoluble
forms that do not correspond to phosphorylated forms. 
The results of all cell cycle
analyses have been compiled in Table 4.
Nuclear Matrix Blot
1(1/2
.. -
.1V
200 kD..
FIG. 27. NuMA in the reforming nuclear matrix. (A) Cells from telophase
early G1 and total interphase were used to prepare nuclear matrix fractions and
analyzed for the presence of NuMA by Western blot. (B) CHO cells were subjected to a
nuclear matrix extraction then fixed and stained with antibodies to NuMA (green) and
tubulin (red).
N
uM
A 
Ch
ar
ac
te
ris
tic
s 
Th
ro
ug
h 
th
e 
C
e
n
 
C
y
c
le
-
 
-
-
"
G
1E
G
1L
D
ist
rib
ut
io
n
n
u
cl
ea
r
sp
in
dl
e 
po
le
n
u
cl
ea
r
n
u
cl
ea
r
n
u
cl
ea
r
n
u
cl
ea
r
Ph
os
ph
or
yl
at
io
St
at
e
F
o
r
m
 
3
F
o
r
m
 
2
F
o
r
m
 
1
To
ta
l S
ol
ub
ilt
y
So
lu
bl
e
54
.
33
.
25
.
In
so
lu
bl
e
45
.
66
.
74
.
So
lu
bi
lty
 o
f P
ho
sp
ho
ry
la
te
d 
Fo
rm
s
F
o
r
m
 
3
io
nl
y
F
o
r
m
 
2
sa
n
di
sa
n
di
F
o
r
m
 
1
sa
n
di
Fo
rm
 1
 - 
in
te
rp
ha
se
 - 
lo
we
st
 m
ob
ilit
y 
fo
rm
s 
- 
so
lu
bl
e
N
A 
- n
ot
 a
va
ila
bl
e
Fo
rm
 2
 - 
m
ito
tic
 - 
in
te
rm
ed
ia
te
 m
ob
ilty
 fo
rm
in
so
lu
bl
e
Fo
rm
 3
 - 
m
ito
tic
 - 
hi
gh
es
t m
ob
ilty
 fo
rm
Ta
bl
e 
4.
 S
um
m
ar
y.
 N
uM
A 
ch
an
ge
s 
th
ou
gh
 th
e 
ce
ll c
yc
le
. N
uM
A'
s 
di
st
rib
ut
io
n,
 p
ho
sp
ho
ry
la
tio
n,
 a
nd
 s
ol
ub
ilty
 s
ta
te
s
re
pr
es
en
te
d 
sc
he
m
at
ica
lly
.
rrT"
D. Discussion
NuMA phosphorylation.
These studies demonstrate that NuMA is a phosphoprotei
in interphase that undergoes
additional phosphorylation events at the G2/M transition and is 
dephosphorylated post-
mitotically in several steps. These phosphorylation events are believed to demarcate
specific points in the ' life cycle ' of NuMA that are important for its 
localization and/or
function. Importantly, this work shows that the mitosis-specific phosphorylation is not
a consequence of the protein s redistribution to the mitotic spindle and that
dephosphorylation is not required for its release from the spindle. In fact, since both
phosphorylation and dephosphorylation of NuMA seem to occur while the protein is 
the nucleus , it appears that these post-translational modifications may regulate nuclear
events.
Prior to its molecular identification, NuMA's distribution pattern was 
analyzed by
many groups (reviewed in (38)). Most observations were the same as those in 
this
study. One exception is an observation by one group that NuMA may not move from the
spindle pole to the reforming nucleus until late telophase via transition through
reformed nuclear pores (44). This was clearly not the case in this and other studies, as
NuMA was detected on condensed chromosomes in early telophase (Figure 24C, (32, 34
42)), well before the nuclear envelope reformation was complete (Figure 25C, 
(65)).
This precise cell cycle analysis was possible using highly synchronized cells (Figure
22) .
I !
NuMA phosphorylation and spindle pole association.
NuMA interacts with both microtubules and centrosomes at the mitotic spindle. For
example, intact microtubules are required for the observed cell cycle specific
distribution pattern (32, 34, 37 , 391. Drug-induced de polymerization of spindle
microtubules results in the redistribution of NuMA throughout the cytoplasm and into
heterogeneously-sized cytoplasmic foci (Figure 21 B, (32 , 37, 391). In addition
NuMA is found at the center of taxol- induced microtubule asters (40 , 501, and in
purified microtubule fractions (40, 501. NuMA's association with centrosomes is
discussed in Chapter 6. Many NuMA antibody microinjection and overexpression studies
have resulted in aberrant spindle formation and function (reviewed in (381). These
data suggest that NuMA plays a role in the formation and stabilty of the mitotic spindle.
A natural assumption from these observations is that the mitotic phosphorylation
events that we describe here affect NuMA's abilty to associate with the mitotic spindle.
Although this study examines only a specific set of mitotic phosphorylation events,
NuMA may undergo many other phosphorylation events not detected in these assays. The
results in this chapter do not support a role for the mitotic phosphorylation events
defined by altered electrophoretic mobilty of NuMA, in spindle association for several
reasons. First , phosphorylation occurs at the time of nuclear disassembly, between G2
and prometaphase , prior to spindle assembly. Second, in mitotic cells lacking spindles,
phosphorylation still occurs. Third, if phosphorylation is required for spindle
association then one would expect that dephosphorylation would be required for
dissociation of NuMA in telophase. However, dephosphorylation of NuMA occurs much
later , in G1. Thus, it is unlikely that the phosphorylation and dephosphorylation events
observed in this study are involved in NuMA's spindle association and dissociation.
However, it is formally possible that other phosphorylation events, not detected by
these analyses, playa role in spindle association, assembly, or stabilzation.
NuMA phosphorylation and nuclear function.
NuMA' s phosphorylation occurs at roughly the same time that it disassemblesfrdm the
nucleus. These events are mechanistically and temporally analogous to the
phosphorylation-driven disassembly of lamin 8. from the nuclear lamina 
(65). Thus, it
is possible that NuMA's disassembly from the nucleus at mitosis is also driven by
phosphorylation. Assembly of lamin 8. into the reforming nuclear lamina occurs
concomitantly with its dephosphorylation (65, 69, 70). In contrast, reassembly of
NuMA into the nucleus does not correlate with its dephosphorylation. In fact, the first
dephosphorylation event occurs after NuMA is already nuclear (Figure 24D) and
partially associated with the nuclear matrix (Figure 27). The dephosphorylation is
complete within 10 minutes (data not shown). This rapid dephosphorylation does not
correlate with NuMA' localization, its detergent-solubilty (Figure 26B) or with
changes in nuclear morphology.
The second dephosphorylation event takes place near the G1/S boundary as demonstrated
by the rapid (not shown) and quantitative shift in electrophoretic mobility (Figure
238.). It is possible that dephosphorylation of NuMA plays a role in the activation 
DNA replication which occurs at this time. In support of this idea are recent data
demonstrating that NuMA binds to matrix attachment regions (MARs) (96), which are
DNA sequences believed to be responsible for organizing chromatin into constrained
loops. MARs have been implicated in the regulation of DNA replication and transcription
(23, 97, 98).
l .
Based on these results, the dephosphorylation events described in this study may playa
role in the assembly of NuMA into higher order structures in the nucleus or in other
nuclear events not detectable in this analysis. Dephosphorylation drives the assembly of
other coiled-coil proteins such as lamin B (66), vimentin (99), and others (100,
101). NuMA is predicted to form a 200 nm fiament based on the amino acid sequence
(42). Indeed, a recent ultrastructural study provides evidence that recombinant full-
length protein forms a 207 nm parallel double-stranded coiled-coil (84). This study
did not find evidence for fiament assembly, however. There is some debate over
whether NuMA wil form filamentous structures via the coiled coil domain since the
sequence lacks periodicity in acidic and basic residues (85). However, the complex
phosphorylation pattern of NuMA in both mitosis and interphase described here may
contribute to changes in charge distribution and tertiary structure of the molecule
which would enable the protein to form filaments.
Regulation of NuMA phosphorylation and dephosphorylation.
The kinases and phosphatases that act on NuMA at different stages of the cell cycle have
not been identified. The mitosis-specific cdc2 kinase may regulate the disassembly of
NuMA from the nucleus as it does the disassembly of lamin B from the nuclear lamina
(67). Although site-directed mutagenesis of the consensus sites for cdc2 kinase in
NuMA affects its subcellular distribution (53), there has been no direct demonstration
that NuMA is a substrate for cdc2 kinase. This wil require the careful identification of
the specific amino acids on NuMA that are phosphorylated at mitosis. There are other
cell cycle-specific phosphoproteins such as DNA topoisomerase II that have been mis-
identified as in vivo substrates for cdc2 kinase (102-105). While this protein is
capable of being phosphorylated by cdc2 in vitro , activation of the enzymatic activity in
vivo was regulated by protein kinase c and casein kinase II phosphorylation events.
CHAPTER 6
CONCLUSIONS AND FUTURE DIRECTIONS
This dissertation is a study of the nuclear matrix and mitotic spindle protein NuMA. In
this work , the partial cDNA for NuMA was cloned and sequenced using nuclear matrix-
specific antibodies and molecular biological methodologies. The cDNAs and antibodies
were used to characterize the gene, mRNA, and protein. NuMA was found to be a single
copy gene located on human chromosome 11q13. The mRNA profile consisted of a major
2 kb species and a minor 8.0 kb species with alternatively spliced exons suggesting
that one or more RNA isoforms were produced from the NuMA gene. A single
phosphoprotei of 250 kDa was detected by immunoprecipitation and Western blot
analysis on interphase mammalian cells. Immunofluorescence microscopy demonstrated
that NuMA oscilated between the nucleus and the mitotic spindle pole during the cell
cycle.
The nature and distribution of NuMA through mitosis was studied in greater detail.
Highly synchronized cell populations were used to demonstrate that the protein was
released from the nucleus at the G2/M transition concomitant with a phosphorylation
event. The mitotic-specific phosphorylation state of NuMA did not change as the protein
transiently associated with the mitotic spindle (metaphase) or as it became a partially
insoluble nuclear component (telophase). NuMA was dephosphorylated in two steps, in
early G1 and in late G1. These changes in phosphorylatio state did not correlate with
changes in the protein s localization or solubilty but may reflect changes in the
function of NuMA in the G1 nucleus. This work contributes to the validation of the
nuclear matrix and opens avenues to identify other nuclear matrix proteins based on
interactions with NuMA. Through these studies, we can begin to understand the cell
cycle regulation of structural proteins and mechanisms of nuclear spindle
organization.
There are at least three pivotal observations from this study that provide the basis for
exciting future studies: 1. the cell cycle specific phosphorylation of NuMA (Figure 23),
2. the identification of a phosphorylated NuMA binding protein (Figure 17), and 3. the
localization of NuMA to the interphase centrosomes (see below, Figure 28). These
potential studies wil be addressed individually below.
The observation that NuMA is phosphorylated in a cell cycle-dependent manner (Figure
23) opens several lines of investigation. Phosphoamino acid analysis and tryptic
peptide mapping should be done to characterize the two mitosis-specific
phosphorylation states. Identification of the specific amino acids that are
phosphorylated may prove useful in the identification of the kinases and phosphatases
that act on NuMA. Future investigations designed to elucidate the mechanism of
phosphorylation and dephosphorylation of NuMA wil , in turn, lead to an understanding
of the regulation of NuMA function. Finally, identification of enzymes that regulate
NuMA function may provide valuable insights into how the protein is coupled to other
cell cycle events which could also lead to information about its role in spindle and
nuclear organization.
The second intriguing observation is that NuMA coprecipitates another phosphorylated
protein of approximately 180 kDa (Figure 17). The identity of the 180 kDa protein is
unknown, but it is not related to NuMA by Western analysis with polyclonal antibodies.
Interestingly, the 180 kDa protein co-precipitates with pericentrin , another
centrosome protein but not with TPR , a nuclear pore protein. If the same 180 kDa
protein is co-precipitated by both NuMA and pericentrin, it may be a highly
phosphorylated centrosomal component that interacts with both proteins. It could be a
kinase that phosphorylates NuMA and pericentrin to target them to the centrosome or
regulate common functional activities. Surprisingly, the 180 kDa phosphoprotein is not
present in the mitotic NuMA immunoprecipitation (Figure 18, lane M). It is well
known that NuMA redistributes to the centrosome at mitosis (Figures 12, 21 , and 24),
so it is surprising that the 180 kDa band is not present in these immunoprecipitations.
However, it has been suggested that there is a fraction of NuMA at the centrosome
throughout the cell cycle (see below). Tryptic peptide analysis of the 180 kDa band
from both NuMA and pericentrin immunoprecipitations may provide the necessary
information to determine whether they are the same or different proteins. Future
studies could then involve identification of this protein through purification and
microsequencing. Finally, identification of the 180 kDa protein by 32P-labeling and
immunoprecipitation suggests that this approach could be used in identifying other
NuMA-interacting proteins in both the nucleus and centrosomes.
The final future direction is derived from preliminary observations suggesting that a
fraction of NuMA is always present in isolated centrosomes (Figure 28). During the
examination of nocodazole-treated cells (Figure 21), foci of NuMA staining were often
observed near or on the centrosome. To further analyze this potential association
centrosomes were isolated from log-phase CHO cells and co-stained for NuMA , tubulin,
and pericentrin. NuMA was detected in each centrosome (Figure 28B) stained with
pericentrin (Figure 28A). The centrosome localization of NuMA was more striking in
preparations where microtubules were regrown from isolated centrosomes and then
fixed and co-stained with tubulin (Figure 28C) and NuMA antibodies (Figure 28D).
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FIG. 28. A portion of NuMA is present in centrosomes at all cell cycle
stages. Centrosome isolated from log-phase CHO cells (Doxsey, 1994) were spun
onto coverslips and costained with pericentrin (A) and NuMA (B). Isolated
centrosomes from whichmicrotubules were regrown (Doxsey, 1994), were stained
for tubulin (C) and NuMA (D). The images in panels C and D were merged in panel E to
show overlap (yellow) with tubulin (Red) and NuMA (Green). Bar Sum.
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Under these conditions, NuMA was located at the center of each microtubule aster
(overlap seen in Figure 28E).
This and other data suggests that a fraction of NuMA is associated with the centrosomes
throughout the cell cycle for the following reasons. First, the centrosome isolation
protocol involves depolymerizing actin and microtubules and releasing centrosomes into
a Triton-soluble fraction (106) separated from the insoluble fraction of NuMA in the
nuclear matrix, which remains on the dish. The cells were rapidly lysed in a large
volume to minimize interactions with non-centrosomal components. Thus , it is unlikely
that nuclear NuMA would contact the centrosomes during the isolation procedure, and
even less likely that NuMA would contact every centrosome (Figure 28). Finally, there
have been other localization studies identifying NuMA at the centrosome throughout the
cell cycle (39, 40, 47) and at the minus end of taxol-stabilzed microtubule asters
(40) .
Results from a recent study suggest that there are NuMA isoforms that exist as resident
centrosome components. It is possible that our antibody crossreacts with this form as it
is a polyclonal serum raised against three separate parts of the protein independently
and pooled together. Two alternatively spliced cDNA constructs that are C-terminal
variants of NuMA mRNA , when expressed in mammalian cells localized specifically to
the centrosome (47). This result suggests that these isoforms of NuMA reside in the
centrosome in small amounts in vivo. There may be specific fixation conditions
necessary to preserve their association or antigenicity. Or they may need to be
unmasked by removing cytoplasmic microtubules or other proteins. Consistent with
this idea is the increased accessibilty of antibodies to centrosome antigens after
microtubule depolymerization , treatment with millimolar amounts of calcium (39), or
103
treatment with reducing agents (107). This would also explain why some images of
NuMA at the mitotic centrosome have negatively stained centers (Figure 12H). Resident
centrosomal NuMA may not be accessible at intact mitotic spindles Future studies such
as Western analysis of purified centrosomes should contribute to our understanding of
the relationship of NuMA with the centrosome.
NuMA is an unusual and intriguing molecule with a complex intracellular distribution
and cell cycle phosphorylation pattern. Results from these and other future studies may
provide crucial information about NuMA's contribution to nuclear, spindle, and
centrosome function.
CHAPTER 7
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